Author Correction: Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization
Saved in:
| Main Authors: | Yugenia K. Hong-Nguyen, Joseph Toerner, Lucia Lee, Maria C. Allende, David C. Kaslow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01092-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization
by: Yugenia K. Hong-Nguyen, et al.
Published: (2024-10-01) -
Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody
by: Bryony Treston, et al.
Published: (2024-12-01) -
Advances in prevention of RSV disease in infants
by: Prof Heather J Zar
Published: (2025-03-01) -
Estimating the Public Health and Economic Impact of Immunisation with Nirsevimab or Maternal Immunisation for the Prevention of RSV-Related Outcomes Over Infants’ First RSV Season in the UK
by: Mersha Chetty, et al.
Published: (2025-07-01) -
Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico
by: José Luis Huerta, et al.
Published: (2025-01-01)